Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upFlorian Lordick, Elizabeth Smyth, Arndt Vogel et al.|Annals of Oncology|2022Cited by 1.4k
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upArndt Vogel, Erika Martinelli, Andrés Cervantes et al.|Annals of Oncology|2018Cited by 1.1k
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trialRobin Kate Kelley, Ming‐Huang Chen, Heinz‐Josef Klümpen et al.|The Lancet|2023Cited by 1k
Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upRadka Obermannová, Elizabeth Smyth, Florian Lordick et al.|Annals of Oncology|2022Cited by 646
Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upArndt Vogel, Michel Ducreux|Annals of Oncology|2022Cited by 611